Daniel Froehlich becomes Head of Finance at Endogena Therapeutics

Zürich, SwitzerlandJanuary 2023

After a long career in different areas of finance and controlling for stock market-listed Swiss multinational groups, SMEs, in different industries, such as medical technology, Daniel decided to join the start-up, biotech pharmaceutical industry. His extensive experience as a CFO and COO will be crucial for our growing company.

We are very fortunate to have such an experienced individual like Daniel joining our team. We have big plans and in our current company stage, having sound financials, controlling and operations in place is now even more important” explains Dr. Matthias Steger, CEO & Co-Founder.